LECTIN BINDING GLYCOPROTEINS IN HUMAN-MELANOMA CELL-LINES WITH HIGH OR LOW TUMORIGENICITY

被引:11
|
作者
BERTHIERVERGNES, O
REANO, A
DORE, JF
机构
[1] CTR LEON BERARD, INSERM, U218, IMMUNOL & CANCEROL EXPTL LAB, 28 RUE LAENNEC, F-69373 LYON 08, FRANCE
[2] HOP EDOUARD HERRIOT, CNRS,UNITE 601,INSERM,U209, RECH DERMATOL & IMMUNOL LAB, F-69374 LYON, FRANCE
关键词
D O I
10.1002/ijc.2910370516
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lectin binding glycoproteins of 5 human malignant melanoma cell lines (HMMCL), differing in their ability to grow subcutaneously in athymic nude mice, were compared by electrophoresis of total cellular proteins and subsequent incubation of SDS-poly-acrylamide gel with 125I-labelled lectins. Despite the similarity between the protein profiles of the different HMMCL, Concanavalia ensiformis agglutinin (ConA), wheat-germ agglutinin (WGA) and peanut agglutinin (PNA) revealed differences in their glycoprotein expression, in contrast with Ulex europaeus agglutinin I (UEA I). A great diversity was observed in the electrophoretic mobilities and/or staining intensities of ConA and WGA binding glycoproteins of HMMCL. However, neither ConA-reactive glycoproteins nor WGA-reactive glycoproteins could be detected that were characteristic of HMMCL with high tumorigenicity (HT) or low tumorigenicity (LT). In contrast, the expression of two cell-surface PNA binding glycoproteins appeared to be related to the tumorigenic phenotype of HMMCL. One of them, with an apparent molecular weight of 190 kDa, was only detected in the LT cell lines. The other, with an apparent molecular weight of 60 kDa, was detected in all HMMCL but became strongly labelled after neuraminidase treatment only the HT cell lines. Thus, the expression of glycoproteins rich in terminal galactose resides may characterize human melanoma cells with different tumorigenic behavior.
引用
收藏
页码:747 / 751
页数:5
相关论文
共 50 条
  • [21] METASTASIS OF HUMAN-MELANOMA CELL-LINES IN IMMUNOSUPPRESSED NEWBORN RATS
    DORE, JF
    BAILLY, M
    BERTRAND, S
    ANTICANCER RESEARCH, 1988, 8 (05) : 1133 - 1134
  • [22] ANTIPROLIFERATIVE EFFECT OF CALMODULIN ANTAGONIST ON HUMAN-MELANOMA CELL-LINES
    SOMEYA, T
    OTSUKA, F
    ISHIBASHI, Y
    CLINICAL RESEARCH, 1986, 34 (02): : A782 - A782
  • [23] INDIRECT IMMUNOFLUORESCENCE EVIDENCE FOR CALMODULIN IN HUMAN-MELANOMA CELL-LINES
    DUTOIT, C
    REYNIER, M
    AQUARON, R
    BULLETIN DU CANCER, 1985, 72 (02) : 75 - 79
  • [24] INTERLEUKIN-6 PRODUCTION BY HUMAN-MELANOMA CELL-LINES
    LEE, JD
    SIEVERS, TM
    SKOTZKO, M
    CHANDLER, CF
    MORTON, DL
    MCBRIDE, WH
    ECONOMOU, JS
    LYMPHOKINE AND CYTOKINE RESEARCH, 1992, 11 (03): : 161 - 166
  • [25] SELECTIVE TOXICITY OF DEOXYADENOSINE ANALOGS IN HUMAN-MELANOMA CELL-LINES
    PARSONS, PG
    BOWMAN, EPW
    BLAKLEY, RL
    BIOCHEMICAL PHARMACOLOGY, 1986, 35 (22) : 4025 - 4029
  • [26] EXPRESSION OF THE GALACTOSE BINDING-PROTEIN MAC-2 BY HUMAN-MELANOMA CELL-LINES
    MEY, A
    BERTHIERVERGNES, O
    APOIL, PA
    DORE, JF
    REVILLARD, JP
    CANCER LETTERS, 1994, 81 (02) : 155 - 163
  • [27] PHYSIOLOGICAL MODULATORS OF DIAMINE OXIDASE (DAO) ACTIVITY IN HUMAN-MELANOMA CELL-LINES - RELATIONSHIP WITH TUMORIGENICITY IN NUDE-MICE
    THOMASSET, N
    QUASH, GA
    DORE, JF
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (09): : 1319 - 1319
  • [28] INHIBITORS OF LYMPHOCYTE-ACTIVATION SECRETED BY HUMAN-MELANOMA CELL-LINES
    GIACOMONI, D
    BENEFRAIM, S
    NAJMABADI, F
    DRAY, S
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1990, 7 (04): : 273 - 280
  • [29] GLUCOCORTICOID RECEPTORS AND CELL-CYCLE PROGRESSION IN HUMAN-MELANOMA CELL-LINES
    OSMAN, AM
    JANSEN, PWM
    SMETS, LA
    BENCKHUIJSEN, C
    JOURNAL OF CELLULAR PHYSIOLOGY, 1985, 125 (02) : 306 - 312
  • [30] EXPRESSION OF THE C-SKI PROTOONCOGENE IN HUMAN-MELANOMA CELL-LINES
    FUMAGALLI, S
    DONEDA, L
    NOMURA, N
    LARIZZA, L
    MELANOMA RESEARCH, 1993, 3 (01) : 23 - 27